Personalized Voice Activated Wellness Assistants for Patients With Heart Failure

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 10, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Heart FailureCongestive Heart Failure
Interventions
DEVICE

Alexa+

Patients will receive the Amazon Echo Dot with Alexa voice technology (Alexa+) and will be asked to interact with the device for 3 months. Alexa+ will ask a series of questions. Based on the answers to these questions, it will either contact a study coordinator or will ask patients to take a specific action (such as weighing themselves). Data from this simple intervention will be merged with data extracted from the patient's health record and analyzed for clinical variables and demographics that are most predictive for success in use of these technologies.

OTHER

Standard of Care Arm

This group will receive standard of care (SOC) HF management, which will entail regular follow up from the HF nurse and data from all hospital or clinic visits will be captured from the EHR.

Trial Locations (1)

20010

MedStar Washington Hospital Center, Washington D.C.

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Georgetown-Howard Universities Center for Clinical and Translational Science

OTHER

collaborator

ObEN Artificial Intelligence

UNKNOWN

lead

Medstar Health Research Institute

OTHER